Diagnosing and managing childhood absence epilepsy by telemedicine

Epilepsy Behav. 2021 Feb:115:107404. doi: 10.1016/j.yebeh.2020.107404. Epub 2020 Dec 13.

Abstract

The diagnosis of childhood absence epilepsy (CAE) is typically based on history and description of spells, supported by an office-based positive hyperventilation test and confirmed by routine electroencephalography (EEG). In the current coronavirus disease 2019 (COVID-19) pandemic, many pediatric neurologists have switched to telemedicine visits for nonemergent outpatient evaluations. We present a series of children diagnosed as having CAE on the basis of a positive hyperventilation test performed during remote televisits. Several of these children were begun on treatment for CAE prior to obtaining an EEG, with significant seizure reduction. Our series documents the feasibility of CAE diagnosis and management by telemedicine.

Keywords: Absence epilepsy; Child; Ethosuximide; Hyperventilation; Seizure; Telemedicine.

MeSH terms

  • Anticonvulsants / therapeutic use*
  • COVID-19 / epidemiology
  • COVID-19 / prevention & control*
  • Child
  • Child, Preschool
  • Disease Management*
  • Electroencephalography / methods
  • Electroencephalography / trends
  • Epilepsy, Absence / diagnosis*
  • Epilepsy, Absence / drug therapy*
  • Epilepsy, Absence / epidemiology
  • Female
  • Humans
  • Hyperventilation / diagnosis
  • Hyperventilation / epidemiology
  • Male
  • Neurologists / trends
  • Pediatricians / trends
  • SARS-CoV-2
  • Telemedicine / methods*
  • Telemedicine / trends
  • Valproic Acid / therapeutic use

Substances

  • Anticonvulsants
  • Valproic Acid